
Mirae Asset Healthcare Fund Direct Growth
Mirae Asset Healthcare Fund Direct Growth
as on 30 Oct 2026
Mirae Asset Healthcare Fund Direct Growth is a Equity mutual fund scheme launched on 02 Jun 2018. The current NAV stands at ₹51.6600 as of 30 Oct 2026. From the funds total AUM, its top holdings include Sun Pharmaceutical at 11.13%, Divis Laboratories at 8.03%, J B Chemicals and Pharmaceuticals at 6.45%, Glenmark Pharmaceuticals at 6.40%, Apollo Hospitals at 6.04%
Scheme Overview
- Inception Date : 02 Jun 2018
- AUM : ₹3,494.44 Cr
- 5Y Returns (CAGR) : 16.63%
- Expense Ratio : 0.62%
- Min. SIP : ₹99
- Min. Lumpsum : ₹5,000
Returns Calculator
basis annualised returns
Investment Type
SIP Amount
Investment Period
5Y
₹ 32.73 L
3.50%
₹ 36.98 L
8.00%
₹ 46.96 L
16.63%
Total Investment
₹ 30,00,000
Returns
₹ 16,95,645 (16.63%)
Maturity Value
₹ 46,95,645
Disclaimer: Fixed deposits offer guaranteed returns. Mutual fund investments carry market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns.
Direct vs Regular Returns
Sorry, No Data Available at this Moment!
Returns vs Category
Sorry, No Data Available at this Moment!
*The above returns are absolute
Returns Vs Nifty 50
Historical Returns
Sorry, No Data Available at this Moment!
Start SIP with as Low as ₹100.
Historical NAV
Sorry, No Data Available at this Moment!
Asset Allocation
AUM
₹ 3,494.44 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Asset Allocation
AUM
₹3,494.44 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Sector Holdings
as of 31 May 2026
| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Healthcare | 98.24% | ||
| Basic Materials | 1.12% | ||
| Other | 0.64% |
Stock Holdings
as of 31 May 2026
| Name | Allocation | Weightage |
|---|---|---|
![]() S Sun Pharmaceutical | 11.13% | |
![]() D Divis Laboratories | 8.03% | |
![]() J J B Chemicals and Pharmaceuticals | 6.45% | |
![]() G Glenmark Pharmaceuticals | 6.40% | |
![]() A Apollo Hospitals | 6.04% | |
![]() L Laurus Labs | 4.35% | |
![]() L Lupin | 4.28% | |
![]() D Dr Reddys Laboratories | 4.27% | |
![]() A Aurobindo Pharma | 4.12% | |
![]() F Fortis Healthcare | 3.88% | |
![]() A Alkem Laboratories | 3.57% | |
![]() K Krishna Institute of Medical Sciences | 3.55% | |
![]() O Onesource Specialty Pharma | 3.26% | |
![]() E Eris Lifesciences | 3.25% | |
![]() S Sai Life Sciences | 3.23% | |
![]() C Cipla | 3.21% | |
![]() A Aster DM Healthcare | 3.10% | |
![]() I IPCA Laboratories | 3.02% | |
![]() D Dr. Lal Path Labs | 2.54% | |
![]() M Max Healthcare Institute | 2.35% | |
![]() G Gland Pharma | 2.23% | |
![]() M Mankind Pharma | 2.07% | |
![]() N Narayana Hrudayalaya | 1.33% | |
![]() A Anthem Biosciences | 1.20% | |
![]() T Treps | 0.79% | |
![]() N Neogen Chemicals | 0.62% | |
![]() B Biocon | 0.56% | |
![]() D Deepak Nitrite | 0.50% | |
![]() T Torrent Pharmaceuticals | 0.46% | |
![]() S Sudeep Pharma | 0.37% | |
![]() N Net Receivables / (Payables) | 0.15% | |
![]() M Mirae Asset Liquid Dir Gr | 0.01% | |
R Rubicon Research | 0.00% | |
![]() S Syngene International | 0.00% | |
![]() W Wockhardt | 0.00% |
Fund Comparison
Fund Details
52W High NAV
-
Min. SIP Amount
₹ 99.00
Min. Lumpsum Amount
₹ 5,000.00
AUM (in Cr.)
₹ 3,494.44
Expense Ratio
0.62%
Lock-in Period
No Lock in Period
52W Low NAV
-
Inception Date
02 Jun 2018
Fund Age
8 Yrs
Benchmark
BSE Healthcare TRI
Scheme Type
Open Ended
Stamp Duty
0.005% (from July 1st 2020)
Exit Load
- Exit load of 1% if redeemed within 1 Month.
Tax Implication
- If you redeem within 1 year, STCG are taxed at 20%; If you redeem after 1 year, and returns exceed ₹1.25 Lakhs in a financial year, LTCG are taxed at 12.5%
Fund Managers
| Name | Qualification |
|---|---|
| Vrijesh Kasera | MBA (Finance), CFA (ICFAI) |
| Tanmay Mehta | B.Com & Chartered Accountant |
Fund Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.
Risk-O-Meter
Investors understand that their principal will be at
Very High Risk
Risk Scale
Low
Moderately Low
Moderate
Moderately High
High
Very High
AMC Information
Mirae Asset Mutual Fund
No. of Schemes
52
Total AUM
₹ 2,02,637.97 Cr
Contact Details
Unit 606,6th Flr,WindsorOff. CST Road,Kalina,Santacruz(E),Mumbai-400098
Contact Details
Unit 606,6th Flr,WindsorOff. CST Road,Kalina,Santacruz(E),Mumbai-400098
FAQs
When was Mirae Asset Healthcare Fund launched?
What is the current NAV of Mirae Asset Healthcare Fund?
What is the AUM of Mirae Asset Healthcare Fund?
What is the rate of return of Mirae Asset Healthcare Fund?
- In the past 1Y: 18.44%
- In the past 3Y: 23.86%
- In the past 5Y: 16.63%
What is the expense ratio of Mirae Asset Healthcare Fund?
What is exit load of Mirae Asset Healthcare Fund?
What is the portfolio of Mirae Asset Healthcare Fund?
- Sun Pharmaceutical: 11.13%
- Divis Laboratories: 8.03%
- J B Chemicals and Pharmaceuticals: 6.45%
- Glenmark Pharmaceuticals: 6.40%
- Apollo Hospitals: 6.04%
Top 3 sectoral holdings include:
- Healthcare: 98.24%
- Basic Materials: 1.12%
- Others: 0.94%
How risky is investing in Mirae Asset Healthcare Fund?
Who is the fund manager Mirae Asset Healthcare Fund?
What is the minimum investment required in Mirae Asset Healthcare Fund?
How to invest in Mirae Asset Healthcare Fund directly?
- Open Demat Account on Dhan if you don't have one.
- Analyze the fund performance.
- Invest via SIP or Lumpsum.

Invest in
Pay 0% Commission!
+91
Or Scan the QR Code to download the Dhan App


































